Making Science Group Statistics
Total Valuation
BME:MAKS has a market cap or net worth of EUR 82.04 million. The enterprise value is 116.47 million.
Market Cap | 82.04M |
Enterprise Value | 116.47M |
Important Dates
The last earnings date was Thursday, April 17, 2025.
Earnings Date | Apr 17, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BME:MAKS has 8.87 million shares outstanding. The number of shares has increased by 3.82% in one year.
Current Share Class | 8.87M |
Shares Outstanding | 8.87M |
Shares Change (YoY) | +3.82% |
Shares Change (QoQ) | +7.41% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.48% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.30 |
PB Ratio | 2.68 |
P/TBV Ratio | n/a |
P/FCF Ratio | 1,632.42 |
P/OCF Ratio | 251.72 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.73, with an EV/FCF ratio of 2,317.49.
EV / Earnings | -67.73 |
EV / Sales | 0.43 |
EV / EBITDA | 14.73 |
EV / EBIT | 22.76 |
EV / FCF | 2,317.49 |
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 1.61.
Current Ratio | 0.75 |
Quick Ratio | 0.71 |
Debt / Equity | 1.61 |
Debt / EBITDA | 6.24 |
Debt / FCF | 981.61 |
Interest Coverage | 1.01 |
Financial Efficiency
Return on equity (ROE) is -6.22% and return on invested capital (ROIC) is 4.34%.
Return on Equity (ROE) | -6.22% |
Return on Assets (ROA) | 1.98% |
Return on Invested Capital (ROIC) | 4.34% |
Return on Capital Employed (ROCE) | 10.35% |
Revenue Per Employee | 298,308 |
Profits Per Employee | -1,875 |
Employee Count | 917 |
Asset Turnover | 1.69 |
Inventory Turnover | 85.35 |
Taxes
In the past 12 months, BME:MAKS has paid 1.01 million in taxes.
Income Tax | 1.01M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.17% in the last 52 weeks. The beta is 1.12, so BME:MAKS's price volatility has been higher than the market average.
Beta (5Y) | 1.12 |
52-Week Price Change | +5.17% |
50-Day Moving Average | 9.06 |
200-Day Moving Average | 8.61 |
Relative Strength Index (RSI) | 49.54 |
Average Volume (20 Days) | 2,477 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:MAKS had revenue of EUR 273.55 million and -1.72 million in losses. Loss per share was -0.20.
Revenue | 273.55M |
Gross Profit | 26.08M |
Operating Income | 5.12M |
Pretax Income | -433,168 |
Net Income | -1.72M |
EBITDA | 5.67M |
EBIT | 5.12M |
Loss Per Share | -0.20 |
Balance Sheet
The company has 19.81 million in cash and 49.33 million in debt, giving a net cash position of -29.52 million or -3.33 per share.
Cash & Cash Equivalents | 19.81M |
Total Debt | 49.33M |
Net Cash | -29.52M |
Net Cash Per Share | -3.33 |
Equity (Book Value) | 30.66M |
Book Value Per Share | 2.90 |
Working Capital | -30.60M |
Cash Flow
In the last 12 months, operating cash flow was 325,913 and capital expenditures -275,658, giving a free cash flow of 50,255.
Operating Cash Flow | 325,913 |
Capital Expenditures | -275,658 |
Free Cash Flow | 50,255 |
FCF Per Share | 0.01 |
Margins
Gross margin is 9.53%, with operating and profit margins of 1.87% and -0.63%.
Gross Margin | 9.53% |
Operating Margin | 1.87% |
Pretax Margin | -0.16% |
Profit Margin | -0.63% |
EBITDA Margin | 2.07% |
EBIT Margin | 1.87% |
FCF Margin | 0.02% |
Dividends & Yields
BME:MAKS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.82% |
Shareholder Yield | n/a |
Earnings Yield | -2.10% |
FCF Yield | 0.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BME:MAKS has an Altman Z-Score of 1.77 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.77 |
Piotroski F-Score | 7 |